KLHL14
gene geneOn this page
Also known as KIAA1384
Summary
KLHL14 (kelch like family member 14, HGNC:29266) is a protein-coding gene on chromosome 18q12.1, encoding Kelch-like protein 14 (Q9P2G3).
The protein encoded by this gene is a member of the Kelch-like gene family, whose members contain a BTB/POZ domain, a BACK domain, and several Kelch domains. The encoded protein possesses six Kelch domains and localizes to the endoplasmic reticulum, where it interacts with torsin-1A.
Source: NCBI Gene 57565 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 67 total
- Druggable target: yes
- MANE Select transcript:
NM_020805
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29266 |
| Approved symbol | KLHL14 |
| Name | kelch like family member 14 |
| Location | 18q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1384 |
| Ensembl gene | ENSG00000197705 |
| Ensembl biotype | protein_coding |
| OMIM | 613772 |
| Entrez | 57565 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 protein_coding
ENST00000358095, ENST00000359358, ENST00000583263, ENST00000891553, ENST00000891554, ENST00000913100
RefSeq mRNA: 1 — MANE Select: NM_020805
NM_020805
CCDS: CCDS32813
Canonical transcript exons
ENST00000359358 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001400609 | 32769645 | 32770634 |
| ENSE00001402907 | 32672673 | 32674797 |
| ENSE00001409458 | 32677173 | 32677330 |
| ENSE00001422669 | 32687155 | 32687233 |
| ENSE00001425747 | 32695463 | 32695552 |
| ENSE00001427230 | 32741928 | 32742049 |
| ENSE00001494892 | 32772667 | 32773023 |
| ENSE00001506059 | 32680169 | 32680327 |
| ENSE00001506061 | 32680409 | 32680599 |
Expression profiles
Bgee: expression breadth ubiquitous, 156 present calls, max score 93.23.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0047 / max 111.6535, expressed in 210 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 171604 | 0.4839 | 150 |
| 171602 | 0.2366 | 117 |
| 171603 | 0.0975 | 57 |
| 171606 | 0.0796 | 39 |
| 171607 | 0.0664 | 35 |
| 171608 | 0.0408 | 5 |
Top tissues by expression
235 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oviduct epithelium | UBERON:0004804 | 93.23 | gold quality |
| seminal vesicle | UBERON:0000998 | 91.93 | gold quality |
| right uterine tube | UBERON:0001302 | 85.96 | gold quality |
| cortical plate | UBERON:0005343 | 85.42 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.00 | gold quality |
| buccal mucosa cell | CL:0002336 | 80.57 | silver quality |
| right lobe of thyroid gland | UBERON:0001119 | 79.75 | gold quality |
| thyroid gland | UBERON:0002046 | 79.44 | gold quality |
| fallopian tube | UBERON:0003889 | 79.41 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 78.44 | gold quality |
| spleen | UBERON:0002106 | 77.23 | gold quality |
| bone marrow cell | CL:0002092 | 76.15 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.84 | gold quality |
| metanephros | UBERON:0000081 | 75.67 | gold quality |
| ileal mucosa | UBERON:0000331 | 72.25 | gold quality |
| lymph node | UBERON:0000029 | 71.83 | gold quality |
| metanephros cortex | UBERON:0010533 | 71.16 | gold quality |
| renal medulla | UBERON:0000362 | 69.86 | gold quality |
| bone marrow | UBERON:0002371 | 68.81 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 67.01 | gold quality |
| kidney | UBERON:0002113 | 66.69 | gold quality |
| vermiform appendix | UBERON:0001154 | 65.43 | gold quality |
| ventricular zone | UBERON:0003053 | 64.76 | gold quality |
| caput epididymis | UBERON:0004358 | 64.38 | gold quality |
| endometrium | UBERON:0001295 | 64.11 | gold quality |
| left uterine tube | UBERON:0001303 | 63.15 | gold quality |
| adrenal tissue | UBERON:0018303 | 62.70 | gold quality |
| ganglionic eminence | UBERON:0004023 | 62.68 | gold quality |
| body of uterus | UBERON:0009853 | 62.64 | gold quality |
| endocervix | UBERON:0000458 | 62.62 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.11 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
169 targeting KLHL14, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-1193 | 100.00 | 65.93 | 529 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-6793-5P | 99.97 | 65.95 | 758 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
Literature-anchored findings (GeneRIF, showing 3)
- Printor is a torsinA-interacting protein implicated in dystonia pathogenesis (PMID:19535332)
- TorsinA ATP hydrolysis is induced upon association with LAP1 and LULL1, type II transmembrane proteins residing in the nuclear envelope and endoplasmic reticulum. (PMID:23569223)
- Novel tumor suppressor, KLHL14, is a subunit of a ubiquitin ligase that associates with the endoplasmic reticulum-associated protein degradation machinery. KLHL14 promotes ubiquitylation of B cell receptor (BCR) subunits and decreases the stability of immature BCR glycoforms in the endoplasmic reticulum, thereby reducing BCR levels. Conversely, loss of KLHL14 promotes BCR-dependent NF-kappaB activation and survival. (PMID:32127472)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | klhl14 | ENSDARG00000045275 |
| mus_musculus | Klhl14 | ENSMUSG00000042514 |
| rattus_norvegicus | Klhl14 | ENSRNOG00000015418 |
Paralogs (54): KLHL13 (ENSG00000003096), KLHL20 (ENSG00000076321), KEAP1 (ENSG00000079999), KLHL42 (ENSG00000087448), KLHL22 (ENSG00000099910), KLHL4 (ENSG00000102271), KLHL2 (ENSG00000109466), KLHL5 (ENSG00000109790), BACH2 (ENSG00000112182), KLHL18 (ENSG00000114648), KLHL24 (ENSG00000114796), IVNS1ABP (ENSG00000116679), KLHL12 (ENSG00000117153), KLHL29 (ENSG00000119771), KBTBD7 (ENSG00000120696), KLHL7 (ENSG00000122550), KLHL31 (ENSG00000124743), KLHDC7B (ENSG00000130487), KLHL36 (ENSG00000135686), KLHL8 (ENSG00000145332), KLHL3 (ENSG00000146021), KLHL35 (ENSG00000149243), KLHL1 (ENSG00000150361), BACH1 (ENSG00000156273), KLHL40 (ENSG00000157119), KLHL10 (ENSG00000161594), KLHL21 (ENSG00000162413), KLHDC8A (ENSG00000162873), KBTBD8 (ENSG00000163376), KBTBD6 (ENSG00000165572), KLHL26 (ENSG00000167487), KLHL30 (ENSG00000168427), KBTBD2 (ENSG00000170852), KLHL6 (ENSG00000172578), KLHL15 (ENSG00000174010), KLHL38 (ENSG00000175946), KBTBD11 (ENSG00000176595), KLHDC7A (ENSG00000179023), KLHL28 (ENSG00000179454), KBTBD3 (ENSG00000182359)
Protein
Protein identifiers
Kelch-like protein 14 — Q9P2G3 (reviewed: Q9P2G3)
Alternative names: Protein interactor of Torsin-1A
All UniProt accessions (2): Q9P2G3, J3QQM3
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with TOR1A, preferentially with the ATP-free form.
Subcellular location. Cytoplasm. Cytosol. Endoplasmic reticulum membrane.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9P2G3-1 | 1 | yes |
| Q9P2G3-2 | 2 |
RefSeq proteins (1): NP_065856* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR006652 | Kelch_1 | Repeat |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR011705 | BACK | Domain |
| IPR015915 | Kelch-typ_b-propeller | Homologous_superfamily |
| IPR017096 | BTB-kelch_protein | Family |
| IPR030584 | KLHL14_BTB_POZ | Domain |
| IPR047027 | KLHL14_BACK | Domain |
Pfam: PF00651, PF01344, PF07707, PF24681
UniProt features (13 total): repeat 6, domain 2, splice variant 2, chain 1, compositionally biased region 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P2G3-F1 | 88.04 | 0.75 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 143 (showing top):
BENPORATH_ES_WITH_H3K27ME3, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, chr18q12, ACTTTAT_MIR1425P, GOCC_NEURON_PROJECTION, CCCAGAG_MIR326, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP, GOBP_PROTEIN_CATABOLIC_PROCESS, GOCC_TRANSFERASE_COMPLEX, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOBP_PROTEOLYSIS, GOCC_CELL_BODY, GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX, GOCC_SOMATODENDRITIC_COMPARTMENT
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (9): endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), cytosol (GO:0005829), actin cytoskeleton (GO:0015629), aggresome (GO:0016235), neuron projection (GO:0043005), neuronal cell body (GO:0043025), cytoplasm (GO:0005737), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cytoplasm | 2 |
| binding | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cytoskeleton | 1 |
| inclusion body | 1 |
| plasma membrane bounded cell projection | 1 |
| somatodendritic compartment | 1 |
| cell body | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
572 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KLHL14 | TOR1A | O14656 | 531 |
| KLHL14 | SYT8 | Q8NBV8 | 440 |
| KLHL14 | RMP24 | Q32NC0 | 399 |
| KLHL14 | TOR1AIP2 | Q8NFQ8 | 392 |
| KLHL14 | TACC2 | O95359 | 388 |
| KLHL14 | RBMS3 | Q6XE24 | 388 |
| KLHL14 | C5orf58 | C9J3I9 | 371 |
| KLHL14 | OAF | Q86UD1 | 363 |
| KLHL14 | PRELID3A | Q96N28 | 356 |
| KLHL14 | L2HGDH | Q9H9P8 | 354 |
| KLHL14 | FLYWCH2 | Q96CP2 | 353 |
| KLHL14 | PKHD1L1 | Q86WI1 | 347 |
| KLHL14 | OSBPL10 | Q9BXB5 | 334 |
| KLHL14 | SLC26A7 | Q8TE54 | 327 |
| KLHL14 | D2HGDH | Q8N465 | 326 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KLHL14 | KCTD21 | psi-mi:“MI:0914”(association) | 0.530 |
| KLHL14 | HSP90AB1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ALG3 | GFAP | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL28 | PRKACB | psi-mi:“MI:0914”(association) | 0.350 |
| TOP3B | PRMT5 | psi-mi:“MI:0914”(association) | 0.350 |
| ZBTB24 | BACH1 | psi-mi:“MI:0914”(association) | 0.350 |
| IGHV4-31 | IGHG2 | psi-mi:“MI:0914”(association) | 0.350 |
| PAX5 | PAX8 | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL14 | ARHGAP32 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (81): FBXL17 (Affinity Capture-MS), FLAD1 (Affinity Capture-MS), NUDCD3 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KCTD21 (Affinity Capture-MS), KLHL14 (Affinity Capture-MS), KLHL14 (Affinity Capture-MS), KLHL14 (Affinity Capture-MS), KCTD21 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), FBXL17 (Affinity Capture-MS), FLAD1 (Affinity Capture-MS), NUDCD3 (Affinity Capture-MS), KLHL14 (Affinity Capture-RNA), KLHL14 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B8YAB1, B1H285, B3DIV9, E9QIN8, E9QJ30, F1QEG2, O88879, Q08CL3, Q08CY1, Q0D2A9, Q13939, Q28068, Q3UQV5, Q3ZCT8, Q503R4, Q5F3N5, Q5R4S6, Q5R663, Q5RG82, Q5XHZ6, Q5XI58, Q5ZI33, Q69ZK5, Q6DFF7, Q6DFU2, Q6Q7X9, Q6V595, Q7ZVQ8, Q86V97, Q8BHI4, Q8BUL5, Q8BWA5, Q8CA72, Q8CDE2, Q8CE33, Q8IXQ5, Q8NAB2, Q8NFY9, Q8R179, Q8WVZ9
Diamond homologs: A0JN76, A1YPR0, A6QQY2, B0WWP2, B1WBS3, B2RXF5, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, C9JR72, D2HEW7, D3ZZC3, E0CZ16, E9Q4F2, F1LZ52, F1MBP6, O14867, O15062, O43167, O88282, O88939, O93567, O94889, O95365, P97302, P97303, Q08CY1, Q0IJ29, Q0P4X6, Q13105, Q16RL8, Q1L8W0, Q2M0J9
SIGNOR signaling
0 interactions.
Disease & clinical
Cancer significance
Clinical variants and AI predictions
ClinVar
67 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 58 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1715 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 18:32674793:GCCCC:G | acceptor_gain | 1.0000 |
| 18:32674794:CCCC:C | acceptor_gain | 1.0000 |
| 18:32674794:CCCCC:C | acceptor_gain | 1.0000 |
| 18:32674795:CCC:C | acceptor_gain | 1.0000 |
| 18:32674795:CCCC:C | acceptor_gain | 1.0000 |
| 18:32674796:CC:C | acceptor_gain | 1.0000 |
| 18:32674796:CCC:C | acceptor_gain | 1.0000 |
| 18:32674796:CCCTG:C | acceptor_loss | 1.0000 |
| 18:32674797:CC:C | acceptor_gain | 1.0000 |
| 18:32674798:C:A | acceptor_loss | 1.0000 |
| 18:32674798:C:CC | acceptor_gain | 1.0000 |
| 18:32674799:T:G | acceptor_loss | 1.0000 |
| 18:32677172:CCATA:C | donor_gain | 1.0000 |
| 18:32680182:T:TA | donor_gain | 1.0000 |
| 18:32680595:CTCTT:C | acceptor_gain | 1.0000 |
| 18:32680597:CTT:C | acceptor_gain | 1.0000 |
| 18:32680598:TT:T | acceptor_gain | 1.0000 |
| 18:32680600:C:CC | acceptor_gain | 1.0000 |
| 18:32687150:CTTA:C | donor_loss | 1.0000 |
| 18:32687151:TTAC:T | donor_loss | 1.0000 |
| 18:32687152:TA:T | donor_loss | 1.0000 |
| 18:32687153:A:AT | donor_loss | 1.0000 |
| 18:32687154:C:CT | donor_loss | 1.0000 |
| 18:32687232:TCCTG:T | acceptor_loss | 1.0000 |
| 18:32687233:CCTGT:C | acceptor_loss | 1.0000 |
| 18:32687234:C:CC | acceptor_gain | 1.0000 |
| 18:32687235:T:C | acceptor_loss | 1.0000 |
| 18:32741926:A:AC | donor_gain | 1.0000 |
| 18:32741927:C:CC | donor_gain | 1.0000 |
| 18:32742057:C:CT | acceptor_gain | 1.0000 |
AlphaMissense
4103 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 18:32677189:C:T | G577D | 1.000 |
| 18:32677192:C:T | G576E | 1.000 |
| 18:32677272:C:A | W549C | 1.000 |
| 18:32677272:C:G | W549C | 1.000 |
| 18:32677274:A:G | W549R | 1.000 |
| 18:32677274:A:T | W549R | 1.000 |
| 18:32680183:C:A | G525V | 1.000 |
| 18:32680183:C:T | G525E | 1.000 |
| 18:32680186:C:T | G524E | 1.000 |
| 18:32680235:G:T | R508S | 1.000 |
| 18:32680265:A:G | W498R | 1.000 |
| 18:32680265:A:T | W498R | 1.000 |
| 18:32680327:C:T | G477E | 1.000 |
| 18:32680409:C:A | G477W | 1.000 |
| 18:32680485:C:A | W451C | 1.000 |
| 18:32680485:C:G | W451C | 1.000 |
| 18:32680487:A:G | W451R | 1.000 |
| 18:32680487:A:T | W451R | 1.000 |
| 18:32680546:C:T | G431E | 1.000 |
| 18:32680596:T:A | R414S | 1.000 |
| 18:32680596:T:G | R414S | 1.000 |
| 18:32687183:A:G | W404R | 1.000 |
| 18:32687183:A:T | W404R | 1.000 |
| 18:32687204:A:C | Y397D | 1.000 |
| 18:32687206:C:G | R396P | 1.000 |
| 18:32695486:C:T | G379E | 1.000 |
| 18:32741943:A:G | W352R | 1.000 |
| 18:32741943:A:T | W352R | 1.000 |
| 18:32742011:C:T | G329E | 1.000 |
| 18:32742014:C:T | G328E | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000001090 (18:32749273 C>A,T), RS1000001745 (18:32736055 T>C), RS1000020346 (18:32691569 C>A,G,T), RS1000032593 (18:32766225 T>C), RS1000056573 (18:32749815 C>T), RS1000057735 (18:32742804 CAA>C), RS1000192231 (18:32763171 A>T), RS1000255492 (18:32722227 A>G), RS1000262670 (18:32769043 T>C), RS1000338977 (18:32736145 T>C), RS1000345560 (18:32756972 G>A,T), RS1000366085 (18:32749512 A>G,T), RS1000395942 (18:32683638 C>A,T), RS1000416502 (18:32728603 A>G), RS1000416615 (18:32711580 A>G)
Disease associations
OMIM: gene MIM:613772 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6196125 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
41 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases expression | 5 |
| Benzo(a)pyrene | affects methylation, decreases expression | 4 |
| trichostatin A | increases expression, affects cotreatment, decreases expression | 3 |
| methylmercuric chloride | decreases expression | 2 |
| entinostat | increases expression, affects cotreatment | 2 |
| Arsenic Trioxide | affects binding, decreases reaction, decreases expression | 2 |
| Ethinyl Estradiol | affects expression | 2 |
| Tetrachlorodibenzodioxin | decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| 4-aminophenylarsenoxide | affects binding, decreases reaction | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression, decreases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Panobinostat | increases expression | 1 |
| Azathioprine | decreases expression | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Calcitriol | increases expression | 1 |
| Demecolcine | decreases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL6094276 | Binding | Binding affinity to KLHL14 (unknown origin) at 10 uM by thermal shift assay | Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.